Abstract
We read with interest the article by Arevalo et al 1 about the development of a tractional retinal detachment (TRD) following the use of intravitreal bevacizumab (Avastin; Genetech Inc., San...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
